Samstag, 19. September 2009

In Re Bristol-Myers Squibb Co. Securities Litigation

Trading Symbol: BMY
CUSIP Number: 110122108

TERMS OF THE SETTLEMENT: The Settlement consists of $125,000,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who during the period after the close of the market on March 21, 2006, through and including August 8, 2006, purchased or acquired common stock of Bristol-Myers Squibb Company.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: NOVEMBER 17, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: DECEMBER 30, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com

Keine Kommentare: